Evidence map›Paper›PMID 32354185›Full record

ArticleMolecules (Basel, Switzerland)2020

Isolation and Identification of Lignans and Other Phenolic Constituents from the Stem Bark of

Wei Li, Hye Jin Yang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Pharmacological Spectrum of Substances Derived fromInternational journal of molecular sciences · 2025
    Review
  2. Article
  3. Quercitrin, the primary active ingredient ofFrontiers in pharmacology · 2025
    Article
  4. Article
  5. International journal of molecular sciences · 2023
    Article
  6. Article
  7. Two Lignan Glycosides fromPharmaceuticals (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Phenolic Constituents fromMolecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Wei LiKorean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Korea.ORCID 0000-0001-7272-7290
Hye Jin YangKorean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Korea.

Funding

Ministry of Education, Science and Technology 2020R1C1C1006749
6 · The paper itself

Abstract

A dibenzylbutane-type lignan (

Indexed as

AlbizziaAnimalsDose-Response Relationship, DrugDrug DesignFuransInhibitory Concentration 50LignansMagnetic Resonance SpectroscopyMass SpectrometryMiceNitric OxidePhenolsPhytochemicalsPlant BarkRAW 264.7 CellsStructure-Activity RelationshipfuranFuransLignansNitric OxidePhenolsPhytochemicalsAlbizia julibrissin DurazzFabaceaelignannitric oxidephenolic

Identifiers

PMID32354185
PMCPMC7248698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.